Loading...
•
Mar 31, 2023
Primerica Q1 2023 Earnings Report
Primerica's Q1 2023 results reflected growth in the Term Life segment and progress in improving the profitability of the Senior Health segment, while economic uncertainty pressured the Investment and Savings Products segment.
Key Takeaways
Primerica reported largely unchanged total revenues of $690.0 million compared to Q1 2022. Net income attributable to Primerica increased 9% to $125.1 million, with earnings per diluted share up 16% to $3.38. The company saw growth in term life sales and distribution, with positive net flows in the Investment and Savings Products business.
New life-licensed representatives increased by 11%, with the life-licensed sales force ending the quarter at 136,430, up 5%.
Term Life face amount issued increased by 14% to $28.1 billion.
Investment and Savings Products experienced positive net flows of $642 million.
Net earnings per diluted share (EPS) increased 16% to $3.38, and return on stockholders’ equity (ROE) was 25.5%.
Revenue by Segment
Forward Guidance
The Company expects to repurchase a total of $375 million of common stock during 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...